Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis.
Antoine BouéFlorence JolyJustine LequesneMarie LangePublished in: Cancer (2024)
There is no consensus on the cognitive impairment induced by hormone therapy for prostate cancer, despite the implications for patients' care and daily life. This synthesis of published studies demonstrated an increase in perceived cognitive difficulties but did not prove a decline in cognitive performance during treatment.
Keyphrases
- prostate cancer
- radical prostatectomy
- cognitive impairment
- end stage renal disease
- physical activity
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- palliative care
- prognostic factors
- randomized controlled trial
- social support
- mental health
- multiple sclerosis
- quality improvement
- clinical practice
- mesenchymal stem cells
- patient reported outcomes
- stem cells
- pain management
- chronic pain
- cell therapy